BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 20113884)

  • 1. Hematopoietic stem cell transplantation for severe combined immune deficiency or what the children have taught us.
    Rappeport JM; O'Reilly RJ; Kapoor N; Parkman R
    Immunol Allergy Clin North Am; 2010 Feb; 30(1):17-30. PubMed ID: 20113884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic stem cell transplantation for severe combined immune deficiency or what the children have taught us.
    Rappeport JM; O'Reilly RJ; Kapoor N; Parkman R
    Hematol Oncol Clin North Am; 2011 Feb; 25(1):17-30. PubMed ID: 21236387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
    Buckley RH; Schiff SE; Schiff RI; Markert L; Williams LW; Roberts JL; Myers LA; Ward FE
    N Engl J Med; 1999 Feb; 340(7):508-16. PubMed ID: 10021471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation for the treatment of immune deficiency states.
    Lenarsky C; Parkman R
    Bone Marrow Transplant; 1990 Dec; 6(6):361-9. PubMed ID: 1965792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell depleted haploidentical bone marrow transplantation for the treatment of children with severe combined immunodeficiency.
    Smogorzewska EM; Brooks J; Annett G; Kapoor N; Crooks GM; Kohn DB; Parkman R; Weinberg KI
    Arch Immunol Ther Exp (Warsz); 2000; 48(2):111-8. PubMed ID: 10807052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
    Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
    Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
    Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation using HLA-matched unrelated donors for patients suffering from severe combined immunodeficiency.
    Grunebaum E; Roifman CM
    Immunol Allergy Clin North Am; 2010 Feb; 30(1):63-73. PubMed ID: 20113887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient].
    Cavazzana-Calvo M; André-Schmutz I; Hacein-Bey S; Schindler J; Vitetta H; Dupuis S; Quartier P; Chedeville G; Vilmer E; Casanova JL; Buffet R; Caillat-Zucman S; Radford I; Le Deist F; Fischer A
    J Soc Biol; 2001; 195(1):65-8. PubMed ID: 11530503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transplantation of genetically modified cells in the treatment of children with SCID: great hopes and recent disappointments].
    Smogorzewska EM; Weinberg KI; Kohn DB
    Med Wieku Rozwoj; 2003; 7(1):27-34. PubMed ID: 13130167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem cell transplantation for severe combined immunodeficiency diseases.
    Cowan MJ; Neven B; Cavazanna-Calvo M; Fischer A; Puck J
    Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):73-5. PubMed ID: 18162224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Searching for alternative hematopoietic stem cell donors for pediatric patients.
    Rocha V; Locatelli F
    Bone Marrow Transplant; 2008 Jan; 41(2):207-14. PubMed ID: 18084331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients.
    Bielorai B; Trakhtenbrot L; Amariglio N; Rothman R; Tabori U; Dallal I; Golan H; Neumann Y; Reichart M; Kaplinsky C; Rechavi G; Toren A
    Bone Marrow Transplant; 2004 Aug; 34(4):317-20. PubMed ID: 15220954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
    Tian Y; Deng YB; Huang YJ; Wang Y
    Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors.
    Eyrich M; Leiler C; Lang P; Schilbach K; Schumm M; Bader P; Greil J; Klingebiel T; Handgretinger R; Niethammer D; Schlegel PG
    Bone Marrow Transplant; 2003 Aug; 32(4):379-90. PubMed ID: 12900774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid full engraftment and successful immune reconstitution after allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in Omenn syndrome.
    Gozdzik J; Czogala W; Skoczen S; Krasowska-Kwiecien A; Wiecha O; Mordel A; Lesko E; Majka M; Kowalczyk D; Zembala M
    Pediatr Transplant; 2009 Sep; 13(6):760-5. PubMed ID: 18992055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+CD25+ regulatory T cell depletion improves the graft-versus-tumor effect of donor lymphocytes after allogeneic hematopoietic stem cell transplantation.
    Maury S; Lemoine FM; Hicheri Y; Rosenzwajg M; Badoual C; Cheraï M; Beaumont JL; Azar N; Dhedin N; Sirvent A; Buzyn A; Rubio MT; Vigouroux S; Montagne O; Bories D; Roudot-Thoraval F; Vernant JP; Cordonnier C; Klatzmann D; Cohen JL
    Sci Transl Med; 2010 Jul; 2(41):41ra52. PubMed ID: 20650872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-haploidentical donor transplantation in severe combined immunodeficiency.
    Friedrich W; Hönig M
    Immunol Allergy Clin North Am; 2010 Feb; 30(1):31-44. PubMed ID: 20113885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb.
    Patel NC; Chinen J; Rosenblatt HM; Hanson IC; Brown BS; Paul ME; Abramson SL; Ritz J; Shearer WT
    J Allergy Clin Immunol; 2008 Dec; 122(6):1185-93. PubMed ID: 19084111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
    Vossen J
    Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.